Steven Robert Pacelli is EVP Managing Director Dexcom V of DEXCOM INC. Currently has a direct ownership of 124,775 shares of DXCM, which is worth approximately $8.97 Million. The most recent transaction as insider was on Jan 24, 2022, when has been sold 250 shares (Common Stock) at a price of $416.77 per share, resulting in proceeds of $104,192. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
0% 3M change
0.98% 12M change
Total Value Held $8.97 Million

Steven Robert Pacelli Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2022
SELL
Open market or private sale
$104,192 $416.77 p/Share
250 Reduced 0.72%
34,620 Common Stock
Dec 23 2021
SELL
Open market or private sale
$143,477 $573.91 p/Share
250 Reduced 0.71%
34,870 Common Stock
Dec 14 2021
SELL
Bona fide gift
-
5,459 Reduced 13.45%
35,120 Common Stock
Nov 23 2021
SELL
Open market or private sale
$153,065 $612.26 p/Share
250 Reduced 0.61%
40,579 Common Stock
Oct 22 2021
SELL
Open market or private sale
$142,500 $570.0 p/Share
250 Reduced 0.61%
40,829 Common Stock
Sep 23 2021
SELL
Open market or private sale
$3,864,548 $573.12 p/Share
6,743 Reduced 14.1%
41,079 Common Stock
Sep 09 2021
SELL
Open market or private sale
$684,142 $541.68 p/Share
1,263 Reduced 2.57%
47,822 Common Stock
Aug 23 2021
SELL
Open market or private sale
$555,892 $515.67 p/Share
1,078 Reduced 2.15%
49,085 Common Stock
Jul 23 2021
SELL
Open market or private sale
$487,427 $451.74 p/Share
1,079 Reduced 2.11%
50,163 Common Stock
Jun 23 2021
SELL
Open market or private sale
$460,053 $426.37 p/Share
1,079 Reduced 2.06%
51,242 Common Stock
May 24 2021
SELL
Open market or private sale
$375,222 $347.75 p/Share
1,079 Reduced 2.02%
52,321 Common Stock
Apr 23 2021
SELL
Open market or private sale
$442,606 $410.2 p/Share
1,079 Reduced 1.98%
53,400 Common Stock
Mar 23 2021
SELL
Open market or private sale
$387,264 $358.91 p/Share
1,079 Reduced 1.94%
54,479 Common Stock
Mar 10 2021
SELL
Open market or private sale
$2,020,013 $362.92 p/Share
5,566 Reduced 9.11%
55,558 Common Stock
Mar 08 2021
BUY
Grant, award, or other acquisition
-
5,301 Added 7.98%
61,124 Common Stock
Feb 23 2021
SELL
Open market or private sale
$439,131 $406.98 p/Share
1,079 Reduced 1.9%
55,823 Common Stock
Feb 19 2021
SELL
Open market or private sale
$756,018 $420.01 p/Share
1,800 Reduced 3.07%
56,902 Common Stock
Jan 22 2021
SELL
Open market or private sale
$398,982 $369.77 p/Share
1,079 Reduced 1.8%
58,702 Common Stock
Dec 23 2020
SELL
Open market or private sale
$389,778 $361.24 p/Share
1,079 Reduced 1.77%
59,781 Common Stock
Nov 23 2020
SELL
Open market or private sale
$344,190 $318.99 p/Share
1,079 Reduced 1.74%
60,860 Common Stock
Oct 23 2020
SELL
Open market or private sale
$435,549 $403.66 p/Share
1,079 Reduced 1.71%
61,939 Common Stock
Oct 01 2020
SELL
Open market or private sale
$84,000 $420.0 p/Share
200 Reduced 0.32%
63,018 Common Stock
Sep 30 2020
SELL
Open market or private sale
$821,380 $410.69 p/Share
2,000 Reduced 3.07%
63,218 Common Stock

Also insider at

OSA
LAAA Merger Corp.
SRP

Steven Robert Pacelli

EVP Managing Director Dexcom V
San Diego, CA

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Track Activities on DXCM